Suppr超能文献

快速代谢的肾移植患者由他克莫司普通制剂转换为缓释制剂后对 BK 病毒血症发生率的影响。

Impact of Converting from Immediate-Release Tacrolimus to Envarsus on BK Viremia Incidence in Kidney Transplant Patients with Rapid Metabolism.

机构信息

Department of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Med Sci Monit. 2023 May 25;29:e939748. doi: 10.12659/MSM.939748.

Abstract

BACKGROUND BK infections have been observed more frequently among people who are rapid metabolizers. The tacrolimus c/d ratio identifies rapid metabolizers after transplantation. Envarsus has a lower peak drug level exposure than tacrolimus and is more pronounced in rapid metabolizers. This study hypothesized that less exposure to high tacrolimus levels through use of Envarsus would reduce the incidence of BK infections. MATERIAL AND METHODS This study prospectively converted 43 consecutive kidney transplant recipients (identified as rapid metabolizers by c/d ratio of.

摘要

背景

在快速代谢者中,更常观察到 BK 感染。移植后,他克莫司 c/d 比值可识别快速代谢者。依维莫司的药物峰浓度暴露低于他克莫司,在快速代谢者中更为明显。本研究假设通过使用依维莫司降低高他克莫司水平的暴露,会降低 BK 感染的发生率。

材料和方法

本研究前瞻性地将 43 例连续的肾移植受者(通过 c/d 比值(.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验